Research theme for competitive and other funds (2):
2023 - 2026 Discovery of drug lead from untapped microbes
2022 - 2024 線虫共生微生物が生産する微生物間シグナル分子の存在意義の解明とその産業利用
Papers (10):
Keiichiro Mukai, Tomoko Shibayama, Yu Imai, Takeshi Hosaka. Phenomenological interpretations of the mechanism for the concentration-dependent positive effect of antibiotic lincomycin on Streptomyces coelicolor A3(2). Applied and Environmental Microbiology. 2023
Yu Imai*, Glenn Hauk*, Jeffrey Quigley, Libang Liang, Sangkeun Son, Meghan Ghiglieri, Michael F. Gates, Madeleine Morrissette, Negar Shahsavari, Samantha Niles, et al. Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis. Nature Chemical Biology. 2022. 18. 11. 1236-1244
Negar Shahsavari, Boyuan Wang, Yu Imai, Miho Mori, Sangkeun Son, Libang Liang, Nils Böhringer, Sylvie Manuse, Michael F. Gates, Madeleine Morrissette, et al. A Silent Operon of Photorhabdus luminescens Encodes a Prodrug Mimic of GTP. mBio. 2022. 13. 3
Nadja Leimer*, Xiaoqian Wu*, Yu Imai*, Madeleine Morrissette, Norman Pitt, Quentin Favre-Godal, Akira Iinishi, Samta Jain, Mariaelena Caboni, Inga V. Leus, et al. A selective antibiotic for Lyme disease. Cell. 2021. 184. 21. 5405-5418.e16
Hundeep Kaur, Roman P. Jakob, Jan K. Marzinek, Robert Green, Yu Imai, Jani Reddy Bolla, Elia Agustoni, Carol V. Robinson, Peter J. Bond, Kim Lewis, et al. The antibiotic darobactin mimics a β-strand to inhibit outer membrane insertase. Nature. 2021. 593. 7857. 125-129
Development of the Potential of Actinomycetes to Produce Secondary Metabolites and Discovery of New Antibiotics by Modulating the RNA Polymerase and/or Ribosome. 2012. 48. 1. 9-15
Patents (1):
Isolated darobactin A analog compounds and compositions thereof